The Ellison Institute of Technology (EIT) Oxford tackles humanity’s greatest challenges by turning science and technology into impactful global solutions. Focused on areas like health, food security, sustainable agriculture, climate change, clean energy, and AI-driven government innovation, EIT Oxford blends groundbreaking research with practical applications to deliver lasting results.
A cornerstone of EIT Oxford’s mission is its upcoming 300,000-square-foot research facility at the Oxford Science Park, set to open in 2027. This cutting-edge campus will feature advanced labs, an oncology and preventative care clinic, and collaborative spaces to strengthen its partnership with the University of Oxford. It will also host the Ellison Scholars, driving innovation for societal benefit.
The Pathogen Mission highlights EIT’s transformative approach, using Whole Genome Sequencing (WGS) and Oracle’s cloud technology to create a global pathogen metagenomics system. This initiative aims to improve diagnostics, provide early epidemic warnings, and guide treatments by profiling antimicrobial resistance. The goal is to deliver certified diagnostic tools for widespread use in labs, hospitals, and public health.
EIT Oxford fosters a culture of collaboration, innovation, and resilience, valuing diverse expertise to drive sustainable solutions to humanity’s enduring challenges.
EIT Oxford is excited to appoint an experienced and visionary Chief Product and Technology Officer (CPTO) to lead the development of transformative solutions in the fight against infectious diseases. Reporting to Dr. Emma Stanton, CEO of the Pathogen Programme, the CPTO will provide strategic leadership across the programme, guiding cross-functional teams to develop scalable, AI/ML-powered technologies that align with EIT’s mission to combat endemic and epidemic threats. Working alongside esteemed figures such as Professor Gil McVean, the CPTO will bridge innovation and real-world application, ensuring solutions meet the highest clinical, regulatory, and ethical standards.
This pivotal role involves defining the overall product and technology strategy, overseeing the development of a next-generation standalone platform, and leading a high-performing team of experts across engineering, product, and data. The CPTO will champion the agile development of scalable cloud architectures and drive automation, detection accuracy, and actionable insights through big data and AI/ML integration. With full autonomy to shape the team and tech roadmap, the successful candidate will position EIT Oxford at the forefront of infectious disease genomics, playing a central role in realising the ambition to create the world’s largest pathogen data and analytics platform.

QUALIFICATIONS & EXPERIENCE:

• 10+ years of senior leadership experience (CPTO, CTO, CPO, or equivalent) in tech-driven organisations within data-intensive industries.
• Proven expertise in handling and integrating multi-modal clinical and omics data, as well as leading teams to develop scalable cloud-native architectures.
• Demonstrable knowledge of big data governance, regulatory compliance (e.g., software as a medical device), and secure data sharing in regulated markets.
• Hands-on experience with AI/ML technologies, data engineering, and analytics workflows in healthcare.
• Strong business acumen, with experience managing budgets exceeding £50M annually.
• Experience collaborating with scientists and working with data at scale, with a product-focused mindset to bridge technical and user requirements.